07.01.2026 • News

Mike Radossich Assumes Role of Syensqo CEO

Seasoned Syensqo business leader to guide the company’s next chapter.

Mike Radossich
Mike Radossich, CEO, Syensqo
© Syensqo

Syensqo recently announced that, further to the announcement made last fall, Mike Radossich has officially assumed the role of Chief Executive Officer and member of the Board of Directors. Mike succeeds Ilham Kadri, who will continue supporting the company as a special advisor to ensure a smooth transition of leadership. These changes are effective from January 1, 2026.

A long-standing Syensqo executive with extensive experience leading global businesses, Mike brings deep industry knowledge and a strong track record of operational excellence. He will steer Syensqo’s next phase as the company continues to focus on creating value for its stakeholders, accelerating sustainable, profitable growth, and driving long-term performance.

Company

Syensqo

rue de la Fusée 98
B-1130 Brussels
Belgium

Company contact







Interview

Navigating Uncertainty and Driving Innovation
Meeting Pharma’s Demand for Speed, Reliability, and Flexibility

Navigating Uncertainty and Driving Innovation

Axplora CCO Arul Ramadurai discusses navigating industry uncertainty, building strategic partnerships, and advancing flexible pharmaceutical manufacturing

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

most read